Literature DB >> 7636775

The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

E M Smets1, B Garssen, B Bonke, J C De Haes.   

Abstract

The Multidimensional Fatigue Inventory (MFI) is a 20-item self-report instrument designed to measure fatigue. It covers the following dimensions: General Fatigue, Physical Fatigue, Mental Fatigue, Reduced Motivation and Reduced Activity. This new instrument was tested for its psychometric properties in cancer patients receiving radiotherapy, patients with the chronic fatigue syndrome, psychology students, medical students, army recruits and junior physicians. We determined the dimensional structure using confirmatory factor analyses (LISREL's unweighted least squares method). The hypothesized five-factor model appeared to fit the data in all samples tested (AGFIs > 0.93). The instrument was found to have good internal consistency, with an average Cronbach's alpha coefficient of 0.84. Construct validity was established after comparisons between and within groups, assuming differences in fatigue based on differences in circumstances and/or activity level. Convergent validity was investigated by correlating the MFI-scales with a Visual Analogue Scale measuring fatigue (0.22 < r < 0.78). Results, by and large, support the validity of the MFI.

Entities:  

Mesh:

Year:  1995        PMID: 7636775     DOI: 10.1016/0022-3999(94)00125-o

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  798 in total

1.  Complaints of fatigue: related to too much as well as too little external stimulation?

Authors:  A E de Rijk; K M Schreurs; J M Bensing
Journal:  J Behav Med       Date:  1999-12

2.  Cancer fatigue--more data, less information?

Authors:  Susan B LeGrand
Journal:  Curr Oncol Rep       Date:  2002-07       Impact factor: 5.075

Review 3.  Fatigue in multiple sclerosis: definition, pathophysiology and treatment.

Authors:  Lauren B Krupp
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

4.  Sex differences in the relations of positive and negative daily events and fatigue in adults with rheumatoid arthritis.

Authors:  Mary C Davis; Morris A Okun; Denise Kruszewski; Alex J Zautra; Howard Tennen
Journal:  J Pain       Date:  2010-05-10       Impact factor: 5.820

5.  Fatigue in the Danish general population. Influence of sociodemographic factors and disease.

Authors:  T Watt; M Groenvold; J B Bjorner; V Noerholm; N A Rasmussen; P Bech
Journal:  J Epidemiol Community Health       Date:  2000-11       Impact factor: 3.710

6.  Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol.

Authors:  Charles L Raison; David B Rye; Bobbi J Woolwine; Gerald J Vogt; Breanne M Bautista; James R Spivey; Andrew H Miller
Journal:  Biol Psychiatry       Date:  2010-05-26       Impact factor: 13.382

7.  Sustained pain reduction through affective self-awareness in fibromyalgia: a randomized controlled trial.

Authors:  Michael C Hsu; Howard Schubiner; Mark A Lumley; John S Stracks; Daniel J Clauw; David A Williams
Journal:  J Gen Intern Med       Date:  2010-06-08       Impact factor: 5.128

Review 8.  ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials.

Authors:  Andrea M Barsevick; Charles S Cleeland; Donald C Manning; Ann M O'Mara; Bryce B Reeve; Jane A Scott; Jeff A Sloan
Journal:  J Pain Symptom Manage       Date:  2010-06       Impact factor: 3.612

9.  Qualities of fatigue and associated chronic conditions among older adults.

Authors:  Susan E Hardy; Stephanie A Studenski
Journal:  J Pain Symptom Manage       Date:  2010-06       Impact factor: 3.612

10.  Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy.

Authors:  Alicia K Smith; Karen N Conneely; Thaddeus W W Pace; Donna Mister; Jennifer C Felger; Varun Kilaru; Mary J Akel; Paula M Vertino; Andrew H Miller; Mylin A Torres
Journal:  Brain Behav Immun       Date:  2014-02-28       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.